Vaccination -- United States -- Congresses : The 2009 H1N1 influenza vaccination campaign : summary of a workshop series / Clare Stroud, Lori Nadig, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Vaccination -- United States -- Planning : Financing vaccines in the 21st century : assuring access and availability / Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine
Vaccination -- United States -- Safety measures -- Databases : Vaccine safety research, data access, and public trust / Committee on the Review of the National Immunization Program's Research Procedures and Data Sharing Program, Board on Health Promotion and Disease Prevention
Vaccination Virus diseases Congresses : Considerations for viral disease eradication : lessons learned and future strategies : workshop summary / Stacey Knobler, Joshua Lederberg, and Leslie A. Pray, editors ; Forum on Emerging Infections, Board on Global Health, Institute of Medicine
Vaccinatopm -- adverse effects : Immunization safety review : vaccinations and sudden unexpected death in infancy / Kathleen Stratton [and others], editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies
2003
1
Vaccine. : Immunization strategies : eradicating meningitis in Sub-Saharan Africa / Sarah Cruickshank and Samantha Grills
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed)
